Pfizer’s CEO, Albert Bourla, Ph.D., has yet to top the $33 million in compensation that he earned on the coattails of megablockbuster COVID-19 sales in 2022, but a $27.6 million pay package after a ...

Oncology is the largest therapeutic area in the pharmaceutical industry by sales, but right now, weight management is the hottest. This market is predicted to grow rapidly in the next decade, ...

Good morning. What happens to an organization after it achieves a moonshot? That has been Albert Bourla’s reality, post-COVID. As the CEO of Pfizer, a company he first joined in 1993, Bourla—a ...

About a month after Pfizer CEO Albert Bourla, Ph.D., told investors that the Big Pharma’s pipeline pruning was mostly done, ...

March 2 (Reuters) - Pfizer (PFE.N), opens new tab CEO Albert Bourla said the company "has ‌a problem" with the U.S. Food and Drug Administration's biologics and vaccines chief, Vinay Prasad, in ...

"We are not going back to before Louis Pasteur times,” declared Pfizer CEO Andrew Bourla on a Tuesday morning analyst call, saying the pharma giant will continue its “long-term investment” in vaccines ...

Pfizer CEO Albert Bourla predicted Thursday that people who have received the company’s covid-19 vaccine will “likely” need a third booster shot within a year to maintain protection against the virus.

We recently published 10 Stocks Jim Cramer Talked About. Pfizer Inc. (NYSE:PFE) is one of the stocks on Jim Cramer talked about. Pharma giant Pfizer Inc. (NYSE:PFE)’s shares are down by 4.7% over the ...

Pfizer's CEO thinks his company will make big waves in the weight loss market. Eli Lilly does have a strong hold on the industry and won't let go anytime soon. Even so, Lilly could carve out a niche ...

Pfizer CEO Albert Bourla said the company "has a problem" with the U.S. Food and Drug Administration's biologics and vaccines chief, Vinay Prasad, in response to a question about the drugmaker's ...